Progyny, Inc. Research and Development Expense of Revenue

Research and Development Expense of Revenue of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development Expense of Revenue for the quarter ending June 29, 2021 was 0.0% (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development Expense of Revenue decreased by NaN%
  • Annual Research and Development Expense of Revenue for 2020 was 0.0% (a NaN% decrease from previous year)
  • Annual Research and Development Expense of Revenue for 2019 was 0.0% (a NaN% decrease from previous year)
  • Annual Research and Development Expense of Revenue for 2018 was 0.0% (a NaN% decrease from previous year)
  • Twelve month Research and Development Expense of Revenue ending June 29, 2021 was 0.0% (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Research and Development Expense of Revenue decreased by NaN% year-over-year
Trailing Research and Development Expense of Revenue for the last four month:
29 Jun '21 30 Mar '21 30 Dec '20 29 Sep '20
0.0% 0.0% 0.0% 0.0%
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development Expense of Revenue of Progyny, Inc.

Most recent Research and Development Expense of Revenueof PGNY including historical data for past 10 years.

Interactive Chart of Research and Development Expense of Revenue of Progyny, Inc.

Progyny, Inc. Research and Development Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 0.0% 0.0%
2020 0.0% 0.0% 0.0% 0.0% 0.0%
2019 0.0% 0.0% 0.0% 0.0% 0.0%
2018 0.0% 0.0% 0.0%
2017 0.0%

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.